Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long-Cheng Li

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancerTakashi Tokizane, Hiroaki Shiina, Mikio Igawa, et al.
International Journal of Cancer|April 1, 2005
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerHideki Enokida, Hiroaki Shiina, Shinji Urakami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancerTatsuya Ogishima, Hiroaki Shiina, Julia E Breault, et al.
Cancer Research|March 23, 2005
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancerHiroaki Shiina, Julia E Breault, William W Basset, et al.
Cancer Research|September 3, 2004
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancerHideki Enokida, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathwayShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancerTakashi Tokizane, Hiroaki Shiina, Mikio Igawa, et al.
International Journal of Cancer|April 1, 2005
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerHideki Enokida, Hiroaki Shiina, Shinji Urakami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancerTatsuya Ogishima, Hiroaki Shiina, Julia E Breault, et al.
Cancer Research|March 23, 2005
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancerHiroaki Shiina, Julia E Breault, William W Basset, et al.
Cancer Research|September 3, 2004
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancerHideki Enokida, Hiroaki Shiina, Mikio Igawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathwayShinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
Pageof 8